Portolano Cavallo advises major healthcare and life sciences clients on transactional/contractual, IP, compliance and regulatory, product liability and litigation matters. Luca Gambini and Elisa Stefanini lead the practice group. Gambini has a particular strength in M&A transactions relating to the life sciences sector, whilst Stefanini focuses on regulatory and compliance matters for pharma, biotech and med-tech clients. Andrea Gritti joined the firm from Gianni & Origoni in March 2023, with Gianpaolo Scandone following from Gatti Pavesi Bianchi Ludovici in June 2023. In July 2023, Enzo Marasà was promoted to partner.
Testimonials
Collated independently by Legal 500 research team.
‘Fully reliable team; technically expert; innovative entrepreneurial approach.'
'Independent firm able to mobilize resources while innovating in its services.’
'Fully reliable team with a cost effective approach, technically expert, innovative Entrepreneurial approach Independant firm able to mobilize resources while innovating in its services.'
'The team led by Elisa Stefanini is capable of providing extremely accurate legal opinions with a practical and concrete approach, taking into account the peculiarity of each case. There is always extreme clarity in communications and great attention to timing. I really appreciate the focus on industry standards and developments.'
Work highlights
Lawyers
Practice head
The lawyer(s) leading their teams.
Elisa Stefanini, Luca Gambini